Marie-Paule Kieny of the Drugs for Neglected Diseases Initiative is on a mission to remind stakeholders and governments that there is a moral imperative to pursue the fight against neglected diseases, as she tells LSIPR.
Marie-Paule Kieny’s accomplishments in the life sciences sector are impressive to say the least.
During her time as assistant director general, health systems and innovation at the World Health Organization (WHO), her most notable achievements included bringing coherence to WHO’s work on health systems to support member states progressing towards Universal Health Coverage and successfully leading the work of WHO on research and development (R&D) against Ebola from 2014 to 2016.
Her other triumphs at WHO include the development and licensing of new vaccines against bacterial meningitis, as well as addressing the global supply of pandemic influenza vaccine through technology transfer and manufacturing, with a focus on developing countries.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
News stories up to a week old and feature articles on the day of publication are accessible with a BASIC FREE ACCOUNT.
Register here for free content, or subscribe for access to archive.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’; and for basic access to the latest news on the website and weekly email news alerts choose the 'BASIC FREE ACCOUNT' registration.
Marie-Paule Kieny, Drugs for Neglected Diseases Initiative, LSIPR 50, World Health Organisation, vaccines, disease, developing countries, drug shortage
